JAMA Internal Medicine最新文献

筛选
英文 中文
Risk of Liver Injury With Potentially Hepatotoxic Drugs. 潜在肝毒性药物的肝损伤风险。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-04 DOI: 10.1001/jamainternmed.2024.5492
Einar S Björnsson
{"title":"Risk of Liver Injury With Potentially Hepatotoxic Drugs.","authors":"Einar S Björnsson","doi":"10.1001/jamainternmed.2024.5492","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.5492","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are Students Ready to Run Student-Run Clinics? 学生们准备好开办学生自办诊所了吗?
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-04 DOI: 10.1001/jamainternmed.2024.4884
Nicholas Peoples, Peter A Ubel
{"title":"Are Students Ready to Run Student-Run Clinics?","authors":"Nicholas Peoples, Peter A Ubel","doi":"10.1001/jamainternmed.2024.4884","DOIUrl":"https://doi.org/10.1001/jamainternmed.2024.4884","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":""},"PeriodicalIF":22.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucagon-Like Peptide-1 Receptor Agonists and Suicidality-Two Important Pieces of Data but an Incomplete Puzzle. 胰高血糖素样肽-1 受体激动剂与自杀--两项重要数据,但仍是一个不完整的谜。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4320
Timothy S Anderson, Deborah Grady
{"title":"Glucagon-Like Peptide-1 Receptor Agonists and Suicidality-Two Important Pieces of Data but an Incomplete Puzzle.","authors":"Timothy S Anderson, Deborah Grady","doi":"10.1001/jamainternmed.2024.4320","DOIUrl":"10.1001/jamainternmed.2024.4320","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1312-1313"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Charting the Waters of Sickle Cell Disease With Target Trial Emulation. 用目标试验模拟绘制镰状细胞病的水域图
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4435
A Parker Ruhl, Matthew M Hsieh, Elizabeth A Stuart
{"title":"Charting the Waters of Sickle Cell Disease With Target Trial Emulation.","authors":"A Parker Ruhl, Matthew M Hsieh, Elizabeth A Stuart","doi":"10.1001/jamainternmed.2024.4435","DOIUrl":"10.1001/jamainternmed.2024.4435","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1372-1373"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimated Savings Under the Medicare High-Value Drug List Model. 医疗保险高价值药品清单模式下的估计节省额。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4846
Christopher L Cai, Aaron S Kesselheim, Benjamin N Rome
{"title":"Estimated Savings Under the Medicare High-Value Drug List Model.","authors":"Christopher L Cai, Aaron S Kesselheim, Benjamin N Rome","doi":"10.1001/jamainternmed.2024.4846","DOIUrl":"10.1001/jamainternmed.2024.4846","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1390-1392"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial. 通过患者指导教育促进去处方化:非随机临床试验。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4739
Katie Fitzgerald Jones, Kelly Stolzmann, Jolie Wormwood, Jacquelyn Pendergast, Christopher J Miller, Michael Still, Barbara G Bokhour, Joseph Hanlon, Steven R Simon, Amy K Rosen, Amy M Linsky
{"title":"Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial.","authors":"Katie Fitzgerald Jones, Kelly Stolzmann, Jolie Wormwood, Jacquelyn Pendergast, Christopher J Miller, Michael Still, Barbara G Bokhour, Joseph Hanlon, Steven R Simon, Amy K Rosen, Amy M Linsky","doi":"10.1001/jamainternmed.2024.4739","DOIUrl":"10.1001/jamainternmed.2024.4739","url":null,"abstract":"<p><strong>Importance: </strong>Patient-directed educational materials are a promising implementation strategy to expand deprescribing reach and adoption, but little is known about the impact across medication groups with potentially different perceived risks.</p><p><strong>Objective: </strong>To examine the impact of a patient-directed education intervention on clinician deprescribing of potentially low-benefit (proton pump inhibitors) or high-risk medications (high-dose gabapentin, diabetes agents with hypoglycemia risks).</p><p><strong>Design, setting, and participants: </strong>This pragmatic multisite nonrandomized clinical trial took place at 3 geographically distinct US Veterans Affairs (VA) medical centers from April 2021 to October 2022. The total study sample was composed of the intervention cohort and the historical control cohort cared for by 103 primary care practitioners (PCPs).</p><p><strong>Intervention: </strong>The primary intervention component was a medication-specific brochure, mailed during the intervention time frame to all eligible patients 2 to 3 weeks prior to upcoming primary care appointments. Patients seen by the same PCPs at the same sites 1 year prior to the study intervention served as controls.</p><p><strong>Main outcome and measures: </strong>The primary binary outcome variable was deprescribing 6 months after the intervention, defined as complete cessation or any dose reduction of the target medication using VA pharmacy dispensing data.</p><p><strong>Results: </strong>The total study sample included 5071 patients. The overall rate of deprescribing among the intervention cohort (n = 2539) was 29.5% compared with 25.8% among the controls (n = 2532). In an unadjusted model, the intervention cohort was statistically significantly more likely to have deprescribing (odds ratio [OR], 1.17 [95% CI, 1.03-1.33]; P = .02). In a multivariable logistic regression model nesting patients within PCPs within sites and controlling for patient and PCP characteristics, the odds of deprescribing in the intervention cohort were 1.21 times that of the control cohort (95% CI, 1.05-1.38; P = .008). The difference in deprescribing prevalence between the intervention and control cohorts (proton pump inhibitors: 29.4% vs 25.4%; gabapentin: 40.2% vs 36.2%; hypoglycemia risk: 27.3% vs 25.1%) did not statistically significantly differ by medication group (P = .90).</p><p><strong>Conclusion and relevance: </strong>This nonrandomized clinical trial found that patient-directed educational materials provided prior to scheduled primary care appointments can effectively promote deprescribing for potentially low-benefit and high-risk medication groups.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT0429490.</p>","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1339-1346"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraceptive Access in the US Post-Dobbs. 后多布斯时代的美国避孕药具使用情况。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.3586
Cynthia C Harper, Katherine Brown, Kavita Shah Arora
{"title":"Contraceptive Access in the US Post-Dobbs.","authors":"Cynthia C Harper, Katherine Brown, Kavita Shah Arora","doi":"10.1001/jamainternmed.2024.3586","DOIUrl":"10.1001/jamainternmed.2024.3586","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1279-1280"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights for Using Jinlida in Diabetes Prevention. 使用金利达预防糖尿病的启示。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4992
Kun Zhao, Xiqiao Xiang, Zhenliang Sun
{"title":"Insights for Using Jinlida in Diabetes Prevention.","authors":"Kun Zhao, Xiqiao Xiang, Zhenliang Sun","doi":"10.1001/jamainternmed.2024.4992","DOIUrl":"10.1001/jamainternmed.2024.4992","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1395-1396"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytisinicline For E-Cigarette Cessation. 用于戒除电子烟的 Cytisinicline。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4409
Rongzhong Huang, Tianyang Hu
{"title":"Cytisinicline For E-Cigarette Cessation.","authors":"Rongzhong Huang, Tianyang Hu","doi":"10.1001/jamainternmed.2024.4409","DOIUrl":"10.1001/jamainternmed.2024.4409","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1392-1393"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurse-Supported Self-Directed Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial. 护士支持的失眠症自我指导认知行为疗法:随机临床试验。
IF 22.5 1区 医学
JAMA Internal Medicine Pub Date : 2024-11-01 DOI: 10.1001/jamainternmed.2024.4419
Christi S Ulmer, Corrine I Voils, Amy S Jeffreys, Maren Olsen, Jennifer Zervakis, Kaitlyn Goodwin, Pamela Gentry, Cynthia Rose, Hollis J Weidenbacher, Jean C Beckham, Hayden B Bosworth
{"title":"Nurse-Supported Self-Directed Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial.","authors":"Christi S Ulmer, Corrine I Voils, Amy S Jeffreys, Maren Olsen, Jennifer Zervakis, Kaitlyn Goodwin, Pamela Gentry, Cynthia Rose, Hollis J Weidenbacher, Jean C Beckham, Hayden B Bosworth","doi":"10.1001/jamainternmed.2024.4419","DOIUrl":"10.1001/jamainternmed.2024.4419","url":null,"abstract":"<p><strong>Importance: </strong>Cognitive behavioral therapy for insomnia (CBTi) is the standard of care for treating insomnia disorder, but access is limited. Alternative approaches are needed to expand access to the standard of care.</p><p><strong>Objective: </strong>To examine the effectiveness of a nurse-supported, self-directed behavioral insomnia intervention for decreasing insomnia severity and improving sleep outcomes among veterans, a population with considerable mental health comorbidity.</p><p><strong>Design, setting, and participants: </strong>This randomized clinical trial included 178 patients with insomnia disorder who were recruited from a Veterans Affairs hospital (Durham VA Healthcare System) from September 2019 to April 2022 and randomized following baseline assessment; follow-ups were conducted at 8 weeks (primary end point) and 6 months. Data analysis was primarily conducted during the summer of 2023 and concluded in May 2024.</p><p><strong>Intervention: </strong>Six weekly phone calls from a nurse interventionist plus assigned treatment manual readings covering CBTi treatment components. The health education manual focused on health topics but not sleep.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the Insomnia Severity Index (score range, 0-28; remission <8; differential improvement of 3 points targeted) score assessed at 8 weeks postrandomization. Secondary outcomes were sleep outcomes, depression, fatigue, treatment response, and remission.</p><p><strong>Results: </strong>Of 178 study participants, the mean (SD) age was 55.1 (13.2) years, and 128 (71.9%) identified as men. At 8 weeks, Insomnia Severity Index scores decreased by an estimated mean (SE) of 5.7 (0.51) points in the intervention group and 2.0 (0.47) points in the control group, a differential mean improvement of 3.7 points (95% CI, -5.0 to -2.4; P < .001). Differences were sustained at 6 months (mean, -2.8; 95% CI, -4.4 to -1.3; P < .001). The intervention also resulted in greater improvements at 8 weeks postrandomization in diary sleep onset latency, wake after sleep onset, and sleep efficiency and actigraphy sleep efficiency; these differences were sustained at 6 months. At 8 weeks, depression and fatigue were significantly reduced, and the odds of treatment response and remission were greater in the intervention group compared with controls.</p><p><strong>Conclusions and relevance: </strong>This randomized clinical trial found that despite greater prevalence of mental health conditions and sleep difficulties among veterans, a nurse-supported self-directed CBTi was more effective than health education control for reducing insomnia severity and improving sleep outcomes. Although less effective than therapist-delivered CBTi, findings were comparable with other trials using modified CBTi protocols.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT03727438.</p>","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"1356-1364"},"PeriodicalIF":22.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信